SAN FRANCISCO: Acumen Journal of Sciences, a new title devoted to the business of life science, debuts this month with a stark black cover and long articles that tackle topics like the future of biology and the stem-cell-research controversy.
The title, published by a San Francisco-based research firm, is aimed at C-suite executives and decision-makers in a broadly defined industry that ranges from biotech to biodefense.
The Journal's editor-in-chief Jason Pontin, who helmed the now-defunct Red Herring, said the new venture won't much resemble his old title, save for an occasionally light tone.
"We're dealing with a much more serious subject matter," said Pontin, "and it's more serious at an economic level because we're dealing with much bigger businesses."
The business model, too, will be different. The Journal will be subscription-based, though it does have nine advertisers lined up for the premier issue.